Pharmacokinetic analysis of bumped-kinase inhibitors in horses demonstrates their potential utility for prevention and treatment of equine protozoal myeloencephalitis
BKI-1708 is a potential compound for EPM prevention and treatment of systemic apicomplexan-related diseases in horses, such as piroplasmosis.
Authors
- Wesley C. Van Voorhis (ORCID: https://orcid.org/0000-0001-6141-2015)
- Kayode K. Ojo (ORCID: https://orcid.org/0000-0002-2007-2170)
- Izabela de Assis Rocha (ORCID: https://orcid.org/0000-0001-9765-813X)
- Tom Kennedy (ORCID: https://orcid.org/0000-0003-4621-5974)
- Ryan Choi (ORCID: https://orcid.org/0000-0001-9374-5893)
- Samuel L.M. Arnold (ORCID: https://orcid.org/0000-0001-8290-2347)
- R Ruby (ORCID: https://orcid.org/0000-0003-3192-4946)
- Jennifer Janes (ORCID: https://orcid.org/0000-0002-2654-7421)
- Matthew A. Hulverson (ORCID: https://orcid.org/0000-0002-3413-4969)
- Beatrice T. Sponseller (ORCID: https://orcid.org/0000-0002-4705-6517)
- Lynn K. Barrett (ORCID: https://orcid.org/0009-0005-6815-7594)
- Allen E. Page (ORCID: https://orcid.org/0000-0001-6023-9230)
- Daniel K. Howe
- K. B. Orr
- Stephen M. Reed
- Jenna L. McPeek
Institutions
- University of Kentucky (US)
- University of Washington (US)
- Davenport University (US)
- Rood and Riddle Equine Hospital (US)
Publication Details
- Journal
- American Journal of Veterinary Research
- Published
- 2025-10-14
- DOI
- https://doi.org/10.2460/ajvr.25.07.0270
- Primary Topic
- Trypanosoma species research and implications
- Type
- article
- Field-Weighted Citation Impact
- 0.00